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Objectives This study sought to evaluate the impact of sex differences on fractional ﬂow reserve
(FFR)-guided percutaneous coronary intervention (PCI).
Background The FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation)
study demonstrated that FFR-guided PCI improves outcomes compared with an angiography-guided
strategy. The role of FFR-guided PCI in women versus men has not been evaluated.
Methods We analyzed 2-year data from the FAME study in the 744 men and 261 women with mul-
tivessel coronary disease, who were randomized to angiography- or FFR-guided PCI. Statistical com-
parisons based on sex were stratiﬁed by treatment method.
Results Although women were older and had signiﬁcantly higher rates of hypertension than men
did, there were no differences in the rates of major adverse cardiac events (20.3% vs. 20.2%, p 
0.923) and its individual components at 2 years. FFR values were signiﬁcantly higher in women than
in men (0.75  0.18 vs. 0.71  0.17, p  0.001). The proportion of functionally signiﬁcant lesions
(FFR  0.80) was lower in women than in men for lesions with 50% to 70% stenosis (21.1% vs.
39.5%, p  0.001) and for lesions with 70% to 90% stenosis (71.9% vs. 82.0%, p  0.019). An FFR-
guided strategy resulted in similar relative risk reductions for death, myocardial infarction, and re-
peat revascularization in men and in women. There were no interactions between sex and treat-
ment method for any outcome variables.
Conclusions In comparison with men, angiographic lesions of similar severity are less likely to be
ischemia-producing in women. An FFR-guided PCI strategy is equally beneﬁcial in women as it is in
men. (J Am Coll Cardiol Intv 2012;5:1037–42) © 2012 by the American College of Cardiology
Foundation
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1038Historically, women have higher in-hospital mortality rates
and are at increased risk for adverse outcomes than men are
after percutaneous coronary intervention (PCI) for coronary
artery disease (CAD) (1,2). Improvements in treatment
modalities, however, have narrowed these sex-associated
differences, with recent studies showing similar outcomes
after PCI in women and men (3–5). Nevertheless, women
are less likely to undergo invasive treatment than are men
(6) and are less frequently enrolled in clinical studies
evaluating coronary revascularization strategies (7).
Fractional flow reserve (FFR) is a validated method for
obtaining reliable functional information of a coronary stenosis.
The FAME (Fractional Flow Reserve Versus Angiography for
Multivessel Evaluation) study demonstrated that FFR-guided
PCI improves outcomes and saves money compared with an
angiography-guided strategy in patients with multivessel CAD
(8–10). However, it is unknown whether the functional
significance of coronary lesions is different between women and
men. Moreover, the role of FFR-guided PCI in women versus
men has not been evaluated. In the current study, we per-
formed a post hoc subanalysis of
the data from the FAME study to
evaluate the impact of sex differ-
ences on FFR and the benefits of
FFR-guided PCI.
Methods
Studydesignandpopulation. This
study was a sex-specific analysis
of the 2-year results of the
FAME study (10). Details re-
garding the design, methods,
and endpoints of this prospec-
ive, multicenter, randomized clinical trial have been re-
orted (8). In brief, 1,005 patients with multivessel CAD
ere randomly assigned to either angiography- or FFR-
uided PCI. All patients had coronary lesions of 50%
iameter stenosis in 2 major epicardial vessels, which,
ased on the angiographic appearance and clinical data,
ere felt to require PCI. Patients randomized to
ngiography-guided PCI underwent stenting of all indi-
ated lesions with drug-eluting stents (DES). In patients
ssigned to FFR-guided PCI, FFR was measured in each
iseased coronary artery and stents were placed only if the
FR was 0.80. Patients were excluded if they had left
ain CAD, prior coronary artery bypass graft surgery, a
ecent ST-segment elevation myocardial infarction (5
ays), cardiogenic shock, or extremely tortuous or calcified
oronary arteries. The study protocol was approved by each
nstitutional Review Board or Ethics Committee, and each
atient provided written informed consent.
Procedure and adjunctive therapy. PCI was performed ac-
Abbreviations
and Acronyms
CAD  coronary artery
disease
DES  drug-eluting stent(s)
FFR  fractional flow
reserve
MACE  major adverse
cardiac event(s)
MI  myocardial infarction
PCI  percutaneous
coronary interventioncording to standard coronary interventional techniques with iDES, with the final interventional strategy left to the discretion
of the treating physician. FFR was measured with a coronary
pressure guidewire (St. Jude Medical Systems, Uppsala, Swe-
den) at maximum hyperemia induced by intravenous adeno-
sine, and hyperemic pressure pullback recordings were per-
formed as necessary (8,11). FFR was defined as the ratio
between the mean distal coronary pressure and the mean aortic
pressure. All patients received dual antiplatelet therapy with
aspirin and clopidogrel for at least 1 year after PCI.
Endpoint. All adverse clinical events were centrally adjudicated
y an independent Clinical Events Committee blinded to
reatment. The primary interest of this reanalysis was the
ccurrence of major adverse cardiac events (MACE), a com-
osite of all-cause death, myocardial infarction (MI), or need
or repeat coronary revascularization, at 2 years after PCI in
ach sex. Secondary endpoints included the individual compo-
ents of MACE. Details on these definitions have been
escribed (8,10). Another main goal of this analysis was to
ompare FFR values between women and men with similar
egrees of CAD by visual estimation.
Statistical analysis. Statistical comparisons based on sex
were stratified by treatment method. Continuous variables
are presented as mean  SD, and categorical variables as
numbers or percentages. Between-group differences in cat-
egorical variables were assessed using the chi-square test or
Fisher exact test, as appropriate, and differences in contin-
uous variables were assessed using Student t test. Analyses
nvestigating the interaction between sex and treatment
ethod were also performed using Breslow-Day test. An-
iographic lesion severity per category and the respective
FR value of each specific lesion were plotted using a
ox-and-whisker plot. Survival curves were constructed
sing the Kaplan-Meier method and compared with the
og-rank test. Patients were censored at 2 years (730 days) or
hen events occurred. Two-tailed p values 0.05 were
onsidered statistically significant. All statistical analysis was
erformed using commercially available software (SPSS
ersion 17 for Windows, SPSS Inc., Chicago, Illinois).
esults
Baseline characteristics and procedural results. Of the 1,005
atients included in the analysis, 744 (74%) were men and
61 (26%) were women. Baseline clinical, angiographic, and
rocedural characteristics according to sex and treatment
ethod are presented in Tables 1 and 2. Compared with
en, women were significantly older (68.3  9.5 years vs.
3.1  10.2 years, p  0.001), had higher rates of
ypertension (72.0% vs. 60.6%, p  0.001), and had higher
ates of unstable angina presentation (39.1% vs. 30.4%,
 0.010). Vessel diameters were significantly smaller in
omen than in men (2.41  0.62 mm vs. 2.51  0.63 mm,
 0.002). Although women had significantly fewer lesionsdentified for stenting (2.6  0.9 vs. 2.8  0.9, p  0.012)
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1039and significantly lower SYNTAX (Synergy Between Percu-
taneous Coronary Intervention With Taxus and Cardiac
Surgery) scores (13.4  6.8 vs. 14.9  9.2, p  0.009) than
men did, the total number (2.3  1.4 vs. 2.4  1.2, p 
.207) and length (42.6  27.0 mm vs. 45.6  27.2 mm,
 0.121) of stents implanted per patient were comparable
etween women and men.
The clinical and angiographic characteristics were well
atched between those randomized to FFR-guided PCI and
o angiography-guided PCI, in the population as a whole
nd based on sex. The procedure times required for FFR- and
ngiography-guided treatment were similar in both men and
omen. However, the volume of contrast agent (for men: 283
37 ml vs. 306  131 ml, p  0.019; for women: 241  115
Table 1. Baseline Characteristics
Total
Men
(n  744)
Women
(n  261) p Value
Age, yrs 63.1  10.2 68.3  9.5 0.001
BMI, kg/m2 28.0  4.6 28.2  5.4 0.728
BSA, m2 2.01  0.19 1.78  0.17 0.001
Angina classiﬁcation* 0.001
I 196 (26.3) 51 (19.5)
II 263 (35.3) 72 (27.6)
III 176 (23.7) 74 (28.7)
IV 109 (14.7) 64 (24.5)
Cardiovascular risk factors
Hypertension 451 (60.6) 188 (72.0) 0.001
Dyslipidemia 528 (71.0) 200 (76.6) 0.078
Current smoker 228 (30.6) 66 (25.3) 0.102
Diabetes mellitus 179 (24.1) 69 (26.4) 0.443
Family history 288 (38.7) 107 (41.0) 0.515
Previous MI 277 (37.2) 90 (34.5) 0.428
Previous PCI 211 (28.4) 64 (24.5) 0.231
Unstable angina
With dynamic ECG changes 109 (14.7) 55 (21.1) 0.016
Without dynamic ECG changes 117 (15.7) 47 (18.0) 0.391
Left ventricular ejection fraction, % 56.7  11.6 58.5  11.3 0.029
Medications
Beta-blocker 570 (76.6) 202 (77.4) 0.797
Calcium antagonist 155 (20.8) 62 (23.8) 0.324
Nitrate 233 (31.3) 113 (43.3) 0.001
Antianginal medications,† n 1.29  0.79 1.44  0.79 0.006
ACE inhibitor or ARB 377 (50.7) 145 (55.6) 0.174
Statin 604 (81.2) 210 (80.5) 0.798
Aspirin 684 (91.9) 235 (90.0) 0.346
EQ-5D score 66.8  18.4 62.4  19.4 0.002
EuroSCORE 2.6  2.1 4.3  1.9 0.001
Values are mean  SD or n (%). *Angina was assessed according to the Canadian Cardiovascula
calcium-antagonists, and nitrates.
ACE angiotensin-converting enzyme; ARB angiotensin II receptor blocker; BMIbodymass i
EuroSCORE European System for Cardiac Operative Risk Evaluation; FFR fractional flow reservel vs. 293  117 ml, p  0.001), the number of DES (foren: 2.0 1.2 vs. 2.8 1.1, p 0.001; for women: 1.6 1.4
s. 2.9  1.2, p  0.001), and the total stent length (for men:
0.0 27.7 mm vs. 51.6 25.4 mm, p 0.001; for women:
1.7  27.4 mm vs. 52.6  22.3 mm, p  0.001) were
ignificantly lower for each sex in patients who underwent
FR-guided therapy compared with those who underwent
ngiography-guided therapy.
Sex differences in clinical outcomes at 2 years. Sex-specific
clinical outcomes at 2-year follow-up are presented in Table 3.
Men and women had similar rates of MACE (20.2% vs.
20.3%, p  0.923), death (3.4% vs. 2.7%, p  0.591), MI
(8.1% vs. 7.7%, p  0.837), and repeat revascularization
(11.4% vs. 12.3%, p  0.717). The event rates were not
different between men and women irrespective of the treat-
FFR-Guided PCI (n  509) Angiography-Guided PCI (n  496)
en
384)
Women
(n  125) p Value
Men
(n  360)
Women
(n  136) p Value
 10.4 69.3  8.7 0.001 63.0  10.0 67.4  10.1 0.001
 4.6 28.2  5.2 0.674 28.1  4.6 28.2  5.7 0.941
 0.19 1.78  0.17 0.001 2.01  0.19 1.78  0.17 0.001
0.016 0.015
(27.9) 25 (20.2) 89 (24.7) 26 (19.1)
(35.4) 34 (27.2) 127 (35.3) 38 (27.9)
(23.7) 41 (32.8) 85 (23.6) 33 (24.3)
(13.0) 25 (20.0) 59 (16.4) 39 (28.7)
(57.3) 92 (73.6) 0.001 231 (64.2) 96 (70.6) 0.178
(71.4) 92 (73.6) 0.628 254 (70.6) 108 (79.4) 0.048
(28.4) 29 (23.2) 0.257 119 (33.1) 37 (27.2) 0.211
(24.0) 31 (24.8) 0.849 87 (24.2) 38 (27.9) 0.388
(39.1) 55 (44.0) 0.328 138 (38.3) 52 (38.2) 0.984
(38.0) 41 (32.8) 0.293 131 (36.4) 49 (36.0) 0.941
(28.9) 35 (28.0) 0.846 100 (27.8) 29 (21.3) 0.144
(13.8) 20 (16.0) 0.543 56 (15.6) 35 (25.7) 0.009
(14.8) 20 (16.0) 0.754 60 (16.7) 27 (19.9) 0.405
 11.1 58.0  10.8 0.368 56.4  12.1 59.0  11.8 0.033
(77.6) 97 (77.6) 0.999 272 (75.6) 105 (77.2) 0.701
(21.9) 37 (39.6) 0.780 71 (19.7) 25 (18.4) 0.736
(31.3) 47 (37.6) 0.189 113 (31.4) 66 (48.5) 0.001
 0.80 1.45  0.77 0.085 1.27  0.78 1.44  0.81 0.028
(49.7) 76 (60.8) 0.031 186 (51.7) 69 (50.7) 0.853
(82.0) 102 (81.6) 0.913 289 (80.3) 108 (79.4) 0.830
(91.7) 113 (90.4) 0.662 332 (92.2) 122 (89.7) 0.369
 18.1 64.3  19.0 0.125 66.3  18.9 60.1  19.6 0.006
 2.0 4.6  1.9 0.001 2.6  2.2 4.0  1.8 0.001
y Functional Classification of Angina Pectoris. †Antianginal medications included beta-blockers,
SAbody surface area; ECG electrocardiogram; EQ-5D EuropeanQuality of Life-5 Dimensions;
yocardial infarction; PCI percutaneous coronary intervention.M
(n 
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1040comparable (78.8  1.5% vs. 78.6  2.6%, p  0.820).
Similarly, there were no significant sex-related differences in
death-, MI-, and repeat revascularization–free survival. After
adjustment for differences in baseline risk factors, 2-year
MACE-free survivals were not different between men and
women irrespective of the treatment method.
FFR values according to angiographic stenosis severity. In
he FFR-guided group, a total of 1,414 lesions were noted in
09 patients. Of these, the FFR was measured successfully in
,329 lesions (1,028 in men and 301 in women) (11). The
Table 2. Angiographic Findings and Procedural Results
Characteristics
Total
Men
(n  744)
Women
(n  261) p Value
Diseased vessels, n 0.162
2 540 (72.6) 201 (77.0)
3 204 (27.4) 60 (23.0)
Lesions intended to treat, n 2.8 0.9 2.6 0.9 0.012
Extent of occlusion by visual estimation 0.219
50% to 70% stenosis 875/2,078 (42.1) 299/686 (43.6)
71% to 90% stenosis 823/2,078 (39.6) 260/686 (37.9)
91% to 99% stenosis 314/2,078 (15.1) 95/686 (13.8)
Total occlusion 66/2,078 (3.2) 32/686 (4.7)
Patients with
Total occlusion 61 (8.2) 30 (11.5) 0.110
Proximal LAD lesion 297 (39.9) 99 (37.9) 0.572
Lesions segments 1, 2, 3, 6, 7, and 11 697 (93.7) 243 (93.1) 0.743
Quantitative coronary analysis
Extent of stenosis, % 60.0 16.6 60.6 18.3 0.447
Minimal luminal diameter, mm 1.02 0.44 0.98 0.45 0.083
Reference diameter, mm 2.51 0.63 2.41 0.62 0.002
Length of lesions per patient, mm 32.7 18.0 27.9 15.9 0.001
SYNTAX score 14.9 9.2 13.4 6.8 0.009
Procedural time, min 70 42 70 46 0.929
Volume of contrast agent used, ml 294 134 268 119 0.006
Total stented length per patient, mm 45.6 27.2 42.6 27.0 0.121
Implanted stents per patient, n 2.4 1.2 2.3 1.4 0.207
Values are mean SD or n (%).
LAD left anterior descending artery; SYNTAX Synergy Between Percutaneous Coronary Inte
Table 3. MACE Between Men and Women
Total
Men
(n  744)
Women
(n  261) p Value
M
(n 
Composite of MACE 149 (20.2) 53 (20.3) 0.923 67
Death 25 (3.4) 7 (2.7) 0.591 10
MI 60 (8.1) 20 (7.7) 0.837 23
Repeat revascularization 85 (11.4) 32 (12.3) 0.717 40
Death or MI 81 (10.9) 26 (10.0) 0.677 32
Values are n (%).MACEmajor adverse cardiac events; other abbreviations as in Table 1.esions were categorized into 50% to 70%, 71% to 90%, and
1% to 99% diameter stenosis by visual estimation. Angio-
raphic lesion severity per category and its respective FFR
alues are presented in Figure 1. FFR values were significantly
igher in women than in men (0.75  0.18 vs. 0.71  0.17,
 0.001). The proportion of functionally significant lesions
FFR0.80) was lower in women than in men for lesions with
0% to 70% stenosis (21.1% vs. 39.5%, p  0.001) and for
esions with 70% to 90% stenosis (71.9% vs. 82.0%, p 
.019). In the 91% to 99% category, the proportion of patients
FFR-Guided PCI (n  509) Angiography-Guided PCI (n  496)
Men
 384)
Women
(n  125) p Value
Men
(n  360)
Women
(n  136) p Value
0.306 0.346
540 (72.6) 96 (76.8) 540 (72.6) 105 (77.2)
204 (27.4) 29 (23.2) 204 (27.4) 31 (22.8)
.8 1.0 2.6 0.9 0.021 2.8 0.9 2.7 0.9 0.243
0.685 0.135
1,088 (43.5) 151/326 (36.2) 402/990 (40.6) 148/360 (41.1)
1,088 (37.9) 118/326 (36.2) 411/990 (41.5) 142/360 (39.4)
1,088 (14.7) 42/326 (12.9) 154/990 (15.6) 53/360 (14.7)
1,088 (4.0) 15/326 (4.6) 23/990 (2.3) 17/360 (4.7)
39 (10.2) 15 (12.0) 0.561 22 (6.1) 15 (11.0) 0.063
159 (41.4) 51 (40.8) 0.905 138 (38.3) 48 (35.3) 0.533
363 (94.5) 114 (91.2) 0.183 334 (92.8) 129 (94.9) 0.408
.0 17.2 60.0 18.5 0.787 60.3 15.9 61.2 18.1 0.478
02 0.45 1.02 0.47 0.855 1.02 0.43 0.95 0.40 0.022
50 0.64 2.46 0.63 0.455 2.52 0.62 2.37 0.60 0.001
.4 17.4 26.9 15.2 0.001 31.9 18.6 28.9 16.5 0.100
.0 9.1 13.1 6.8 0.020 14.8 9.4 13.7 6.8 0.233
71 40 70 53 0.950 70 45 70 40 0.960
83 137 241 115 0.002 306 131 293 117 0.330
.0 27.7 31.7 27.4 0.004 51.6 25.4 52.6 22.3 0.693
.0 1.2 1.6 1.4 0.003 2.8 1.1 2.9 1.2 0.470
With Taxus and Cardiac Surgery; other abbreviations as in Table 1.
FFR-Guided PCI Angiography-Guided PCI
Women
(n  125) p Value
Men
(n  360)
Women
(n  136) p Value
24 (19.2) 0.657 82 (22.8) 29 (21.3) 0.729
3 (2.4) 0.900 15 (4.2) 4 (2.9) 0.526
8 (6.4) 0.868 37 (10.3) 12 (8.8) 0.628
14 (11.2) 0.805 45 (12.5) 18 (13.2) 0.826
11 (8.8) 0.871 49 (13.6) 15 (11.0) 0.444(n
2
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1041with FFR 0.80 was not different between women and men
(97.5% vs. 96.2%, p  0.682).
Similarly, the proportion of functionally significant lesions
was significantly lower in women than in men with stenosis in
the 50% to 90% range measured by quantitative coronary
analysis: for 50% to 70% stenosis (54.5% vs. 65.2%, p 0.032)
and for 70% to 90% stenosis (77.6% vs. 89.6%, p  0.017).
Risk reduction with FFR-guidance. During the 2-year
ollow-up, MACE occurred in 17.4% in the FFR-guided
roup and in 22.8% in the angiography-guided group for
en and in 19.2% and in 21.3%, respectively, for women.
he death, MI, and repeat revascularization rates were
.6%, 6.0%, and 10.4%, respectively, in FFR-guided group
ersus 4.2%, 10.3%, and 12.5%, respectively, in
ngiography-guided group for men and 2.4%, 6.4%, and
1.2% versus 2.9%, 8.8%, and 13.2% for women. The 2-year
urvivals free from MACE are depicted in Figure 2.
The relative risk reductions for death, MI, and repeat
evascularization of FFR relative to angiography-guided
reatment were 37%, 42%, and 17%, respectively, in men
nd 18%, 27%, and 15%, respectively, in women. Treatment
ethod-by-sex interaction tests were not statistically signif-
cant for any of the outcome variables (p  0.05).
iscussion
The 3 main findings of this study are: 1) the proportion of
functionally significant lesions (FFR 0.80) is lower in
women than in men with coronary stenoses between 50%
and 90% narrowed; 2) an FFR-guided PCI strategy is
equally beneficial in women as it is in men; and 3) although
women in this study were older and tended to have higher
rates of baseline comorbidities, their 2-year rates of cardiac
events are similar to those in men irrespective of treatment
strategy (FFR- or angiography-guided therapy).
FFR, a lesion-specific index, is superior to noninvasive
Figure 1. FFR Values According to Angiographic Stenosis Severity
FFR  fractional ﬂow reserve.modalities for assessing the ischemic propensity of individualcoronary lesions (12). Although it has been increasingly used to
guide clinical decision making in several patient and lesion
subsets (8,13–15), the differences in FFR results in women and
men have not been previously evaluated. We demonstrated
significantly higher FFR values in women than in men, despite
a similar degree of angiographic stenosis and minimal luminal
diameter. The proportion of functionally significant lesions
(FFR 0.80) was significantly lower in women than in men
or lesions with 50% to 90% stenosis, which suggests that
esions of similar angiographic severity are less likely to be
schemia-producing in women.
Higher FFR for similar angiographic stenosis in women
ay be a chance finding. However, a potential explanation
or this finding is that in this study and others, women were
lder and more likely to have hypertension and left ventric-
lar hypertrophy. One would expect them to have a greater
egree of diastolic dysfunction, although this was not
pecifically studied. These abnormalities could result in
icrovascular dysfunction (16), less hyperemia, and lower
eak flow across any given stenosis, manifesting as a higher
FR. It could also possibly be explained by the fact that
ecause women generally have smaller myocardial mass
17), a smaller myocardial perfusion territory will be sub-
ended by a stenosed vessel (18) and the flow across any
iven stenosis may be less (19), thereby requiring a more
evere stenosis to be functionally significant. The higher
FR values in women in this study might also be due to the
isual estimation of stenosis severity, which has been previ-
usly shown to be more variable and inaccurate in women,
resumably due to vessel size (20,21).
We found no interaction between sex and the benefits of
FR-guided PCI over angiography-guided PCI on 2-year
ates of MACE. As this was a post-hoc subset analysis and
he number of patients in each subgroup was below the
tatistical power needed for significance, caution is required
Figure 2. Kaplan-Meier Curves of Freedom From MACEFFR  fractional ﬂow reserve; MACE  major adverse cardiac events.
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ogeneity in benefit of FFR guidance among the subgroups
for any of the outcome variables (p values were all 0.05).
Our study suggests that FFR-guided therapy is superior to
angiography-guided therapy in reducing adverse clinical
events after multivessel PCI, regardless of sex.
The final finding in this study is that the results of PCI in
women, whether guided by FFR or angiography were equiv-
alent to those in men. Older studies have shown that women
have worse outcomes compared with men undergoing PCI
(1,2). More contemporary studies incorporating modern med-
ical therapy and use of DES have shown no difference in
outcomes between sex (3–5). The results of the current study,
which incorporates modern medical therapy and DES, found
similar 2-year rates of cardiac events in men and women.
Study limitations. The main limitations of this study include
hat it was a post hoc subanalysis of patients in the FAME
tudy and therefore the findings should only be hypothesis
enerating. Because a relatively small number of women were
ncluded, the subanalysis is underpowered to determine
hether FFR-guided therapy is superior to angiography-
uided therapy in women with multivessel disease. Although
aution is required in generalizing our findings to all patients
ith multivessel disease, this study was the first, to our
nowledge, to evaluate the effect of sex differences on FFR-
uided therapy for multivessel coronary intervention.
onclusions
The clinical implications of this study are important. Because
women appear to have higher FFR values for a given stenosis,
it may be even more relevant to measure FFR in women to
confirm hemodynamic significance before performing PCI.
In conclusion, angiographic lesions of similar severity are less
likely to be ischemia-producing in women as compared to men
and an FFR-guided PCI strategy in patients with multivessel
disease is equally beneficial in women as it is in men.
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